Association of right-sided tumors with high thymidine phosphorylase gene expression levels and the response to oral uracil and tegafur/leucovorin chemotherapy among patients with colorectal cancer. (Q54302628)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Association of right-sided tumors with high thymidine phosphorylase gene expression levels and the response to oral uracil and tegafur/leucovorin chemotherapy among patients with colorectal cancer.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

Association of right-sided tumors with high thymidine phosphorylase gene expression levels and the response to oral uracil and tegafur/leucovorin chemotherapy among patients with colorectal cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Sotaro Sadahiro

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

Toshiyuki Suzuki

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

Akira Tanaka

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

Kazutake Okada

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

Hideki Nagase

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

Junji Uchida

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

publication date

30 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

70

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

285-291

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

5-Fluorouracil: mechanisms of action and clinical strategies

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Impact of schedule on leucovorin potentiation of fluorouracil antitumor activity in dietary folic acid deplete mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Expression and clinical significance of methylenetetrahydrofolate reductase in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Molecular determinants of folate levels after leucovorin administration in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Thymidine phosphorylase is angiogenic and promotes tumor growth.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Thymidine Phosphorylase Mediates the Sensitivity of Human Colon Carcinoma Cells to 5-Fluorouracil

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1909-8

21 January 2018

Identifiers

10.1007/S00280-012-1909-8

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22752215

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54302628&oldid=2212415496"